Privacy settings

We use technical cookies, that are necessary for the management of the website, statistical cookies and marketing cookies (including third parties cookies) for displaying individual offers and ads. For more information read our Privacy Policy. Statistical cookies and marketing cookies (inclusive of third parties cookies) are used only with your consent. By clicking “Select all and agree” you consent to our use of statistical and/or marketing cookies (inclusive of third parties cookies).

To customize your privacy settings, tick your preferences in the checkboxes and click “Apply selection”. You can always change the privacy settings and deactivate cookies by following the instructions in the Privacy Policy.

Show preferences Select all and accept
IMA is loading

Main Financial Data 2002

Main Data: 31/12 Year 2002
Consolidated statement of income (international practice in accordance with IAS/IFRS) Millions/Euro
– total revenues 353.41
– gross margin 160.06
– total operating cost 107.86
– net operating profit 47.12
– financial expenses, net 4.25
– net income before taxes 24.43

 

Consolidated balance sheet Millions/Euro
– operating capital 84.95
– fixed assets, net 105.72
– reserves and MLT non financial payables – 14.25
– net financial position – 67.25
– stockholders’ equity 109.17

 

Other information Millions/Euro
– depreciation 15.00
– R & D expenses 18.38

 

  Euro
Dividend per share 0.40

 

  No.
Employees 2,344

 

  Euro
Shares outstanding 18,772,000

 

Main Data: 30/06 Year 2002
Consolidated statement of income (international practice in accordance with IAS/IFRS) Millions/Euro
– total revenues 136.30
– gross margin 61.35
– total operating cost 53.47
– net operating profit 5.49
– financial expenses, net 9.99
– net income before taxes 6.08

 

Consolidated balance sheet Millions/Euro
– operating capital 77.46
– fixed assets, net 110.28
– reserves and MLT non financial payables – 25.35
– net financial position – 71.38
– stockholders’ equity 91.01

 

Other information Millions/Euro
– depreciation 7.31
– R & D expenses 9.50

 

  No.
Employees 2,320

 

  Euro
Shares outstanding 18,772,000

 

Net Sales by Sector: Year 2002
  Millions/Euro  
tea, herbs & coffee 49.78 14.09%
pharmaceuticals packaging 208.35 58.95%
pharmaceuticals processing 95.28 26.96%
Total 353.41 100.00%

 

Net Sales by Country: Year 2002
  Millions/Euro  
E.U. (excluding Italy) 139.18 39.38%
Other European countries 30.00 8.49%
North America 77.55 21.94%
Asia & Middle East 46.66 13.20%
Other countries 29.99 8.49%
Total exports 323.38 91.50%
Italy 30.03 8.50%
Total 353.41 100.00%